Researchers have indicated that CRC patients whose tumors exhibit strong co-expression of CXCR4 and VEGF (Vascular Endothelial Growth Factor) in more than 50% of cells have particularly poor prognoses, with this expression profile serving as a strong and independent predictor of early distant metastasis [93]. Here, CXCR4 is linked to colorectal carcinoma.